KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Current Deferred Tax Assets: 2009-2017

Historic Current Deferred Tax Assets for Idexx Laboratories (IDXX) over the last 9 years, with Dec 2017 value amounting to $23.5 million.

  • Idexx Laboratories' Current Deferred Tax Assets rose 56.75% to $30.4 million in Q1 2018 from the same period last year, while for Mar 2018 it was $30.4 million, marking a year-over-year increase of 56.75%. This contributed to the annual value of $23.5 million for FY2017, which is 30.05% up from last year.
  • According to the latest figures from FY2017, Idexx Laboratories' Current Deferred Tax Assets is $23.5 million, which was up 30.05% from $18.1 million recorded in FY2016.
  • Over the past 5 years, Idexx Laboratories' Current Deferred Tax Assets peaked at $39.8 million during FY2015, and registered a low of $18.1 million during FY2016.
  • Over the past 3 years, Idexx Laboratories' median Current Deferred Tax Assets value was $23.5 million (recorded in 2017), while the average stood at $27.1 million.
  • As far as peak fluctuations go, Idexx Laboratories' Current Deferred Tax Assets crashed by 54.59% in 2016, and later surged by 30.05% in 2017.
  • Over the past 5 years, Idexx Laboratories' Current Deferred Tax Assets (Yearly) stood at $33.2 million in 2013, then increased by 13.43% to $37.7 million in 2014, then increased by 5.68% to $39.8 million in 2015, then tumbled by 54.59% to $18.1 million in 2016, then spiked by 30.05% to $23.5 million in 2017.